PMV Pharmaceuticals

(NASDAQ) PMVP

Current Price$1.21

Market Cap$64.53M

Since IPO (2020)-97%

5 Year-96%

1 Year+13%

1 Month-4%

PMV Pharmaceuticals Financials at a Glance

Market Cap

$64.53M

Revenue (TTM)

$0.00

Net Income (TTM)

-$78.34M

EPS (TTM)

-$1.48

P/E Ratio

-0.82

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Price

$1.21

Volume

17,841

Open

$1.21

Price

$1.21

Volume

17,841

Open

$1.21

Previous Close

$1.21

Daily Range

$1.20 - $1.26

52-Week Range

$0.96 - $1.88

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Price

$1.21

Volume

17,841

Open

$1.21

Previous Close

$1.21

Daily Range

$1.20 - $1.26

52-Week Range

$0.96 - $1.88

Estimated Earnings Date

Aug 13, 2026

PMVP News

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PMV Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David H. Mack, PhD

Website

www.pmvpharma.com

Headquarters

Princeton, NJ 08512, US

PMVP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-68.98%

Return on Capital

-81.67%

Return on Assets

-81.13%

Earnings Yield

-1.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$64.53M

Shares Outstanding

53.33M

Volume

17.84K

Avg. Volume

381.31K

Financials (TTM)

Gross Profit

-$66.00K

Operating Income

-$83.66M

EBITDA

-$78.19M

Operating Cash Flow

-$74.99M

Capital Expenditure

-$25.00K

Free Cash Flow

-$75.02M

Cash & ST Invst.

$93.55M

Total Debt

$293.00K

PMV Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$34.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$64.53M

N/A

Market Cap/Employee

$1.37M

N/A

Employees

N/A

Net Income

-$18.04M

-3.5%

EBITDA

-$18.00M

+8.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$93.55M

-41.7%

Total Debt

$293.00K

-73.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$293.00K

-19.5%

Return on Assets

-81.13%

N/A

Return on Invested Capital

-95.11%

N/A

Free Cash Flow

-$19.68M

-7.7%

Operating Cash Flow

-$19.68M

-7.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CBUSCibus, Inc.

CBUSCibus, Inc.$1.39+1.13%

ATYRaTyr Pharma, Inc.

ATYRaTyr Pharma, Inc.$0.58+8.77%

TCRXTScan Therapeutics, Inc.

TCRXTScan Therapeutics, Inc.$0.90-2.20%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.26+2.44%

ACRVAcrivon Therapeutics, Inc. Common Stock

ACRVAcrivon Therapeutics, Inc. Common Stock$1.67+2.45%

LITSLite Strategy, Inc.

LITSLite Strategy, Inc.$0.87-2.40%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$8.00+0.28%

PLSMPulsenmore

PLSMPulsenmore$8.83+1.59%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.26+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.03+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.07-0.00%

SMCISuper Micro Computer

SMCISuper Micro Computer$32.47-0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.91-0.04%

Questions About PMVP

What is the current price of PMV Pharmaceuticals?

PMV Pharmaceuticals is trading at $1.21 per share.

What is the 52-week range for PMV Pharmaceuticals?

Over the past 52 weeks, PMV Pharmaceuticals has traded between $0.96 and $1.88.

How much debt does PMV Pharmaceuticals have?

As of the most recent reporting period, PMV Pharmaceuticals reported total debt of $293.00K.

How much cash does PMV Pharmaceuticals have on hand?

PMV Pharmaceuticals reported $39.13M in cash and cash equivalents in its most recent financial results.

What is PMV Pharmaceuticals’s dividend yield?

PMV Pharmaceuticals does not currently have a dividend yield.

PMV Pharmaceuticals

PMV Pharmaceuticals Financials at a Glance

PMVP News

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PMV Pharmaceuticals

PMVP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PMV Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PMVP

What is the current price of PMV Pharmaceuticals?

What is the 52-week range for PMV Pharmaceuticals?

How much debt does PMV Pharmaceuticals have?

How much cash does PMV Pharmaceuticals have on hand?

What is PMV Pharmaceuticals’s dividend yield?

Premium Investing Services